Literature DB >> 6343176

Hepatocyte handling of immunoglobulin A in the rat: the role of microtubules.

I S Goldman, A L Jones, G T Hradek, S Huling.   

Abstract

Plasma-derived dimeric immunoglobulin A is transported through liver parenchymal cells into bile, in association with its glycoprotein receptor secretory component, by a vesicular transport system. This study was designed to determine the effects of colchicine, a microtubule-disrupting agent, and thus the role of microtubules on the uptake, intracellular transport, and subsequent biliary secretion of dimeric immunoglobulin A. In vivo studies in rats showed that colchicine treatment reduced the amount of intraportally injected 125I-dimeric immunoglobulin A that appeared in the bile. It was also found that although the livers in colchicine-treated animals could sequester and internalize immunoglobulin A, it was not readily secreted into bile. In vitro studies using peroxidase-labeled antisecretory component and 125I-dimeric immunoglobulin A autoradiography were both used to determine the site of this block in immunoglobulin A secretion. These studies demonstrate that colchicine disruption of microtubules (a) has little initial effect on the binding and internalization of dimeric immunoglobulin A; (b) has a major effect on the translocation of immunoglobulin A-containing vesicles within the hepatocyte, and (c) most likely prevents the translocation of newly synthesized secretory component to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343176

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  Impact of aging on gastrointestinal mucosal immunity.

Authors:  D L Schmucker; M F Heyworth; R L Owen; C K Daniels
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  Molecular and cellular mechanisms involved in transepithelial transport.

Authors:  E Schaerer; M R Neutra; J P Kraehenbuhl
Journal:  J Membr Biol       Date:  1991-08       Impact factor: 1.843

Review 3.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

4.  Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion.

Authors:  R J Coffey; L J Kost; R M Lyons; H L Moses; N F LaRusso
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

5.  Fluid phase endocytosis by cultured rat hepatocytes and perfused rat liver: implications for plasma membrane turnover and vesicular trafficking of fluid phase markers.

Authors:  B F Scharschmidt; J R Lake; E L Renner; V Licko; R W Van Dyke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 6.  Biochemistry of bile secretion.

Authors:  R Coleman
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 7.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

8.  The effects of colchicine on secretion into bile of bile salts, phospholipids, cholesterol and plasma membrane enzymes: bile salts are secreted unaccompanied by phospholipids and cholesterol.

Authors:  S G Barnwell; P J Lowe; R Coleman
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

9.  Investigation of endosomal compartments involved in endocytosis and transcytosis of polymeric immunoglobulin A by subcellular fractionation of perfused isolated rat liver.

Authors:  J H Perez; W J Branch; L Smith; B M Mullock; J P Luzio
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

10.  Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile. Effects of alpha-naphthylisothiocyanate and colchicine.

Authors:  P J Lowe; K S Kan; S G Barnwell; R K Sharma; R Coleman
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.